When asked about the biggest challenge in today’s bioprocessing, Sandy Williams, PhD, a biomedical engineering expert at Scientific Bioprocessing (SBI) in Pittsburgh who focuses on regenerative medicine, says, “The biggest concern we have heard from the industry is that bioprocessing is undersampled. While scaled-up upstream processes are well monitored and controlled, small-scale upstream cultures and downstream bioprocessing appear to be largely undersampled and poorly monitored.”
